26CA0591 Peo in Interest of Keene 07-30-2026
COLORADO COURT OF APPEALS
Court of Appeals No. 26CA0591 Pueblo County District Court No. 26MH30035 Honorable Gregory J. Styduhar, Judge
The People of the State of Colorado,
Petitioner-Appellee,
In the Interest of Andrew Michael Keene,
Respondent-Appellant.
ORDER AFFIRMED
Division V Opinion by JUDGE SCHUTZ Lipinsky and Yun, JJ., concur
NOT PUBLISHED PURSUANT TO C.A.R. 35(e) Announced July 30, 2026
Cynthia Mitchell, County Attorney, Kate H. Shafer, Special Assistant County Attorney, Pueblo, Colorado, for Plaintiff-Appellee
Tezak Law, P.C., Mary Tezak, Florence, Colorado, for Respondent-Appellant ¶1 Andrew Michael Keene appeals the district court’s order
authorizing staff at the Colorado Mental Health Hospital in Pueblo
(the hospital) to medicate him without his consent. We affirm.
I. Background
¶2 Keene was admitted to the hospital in December 2025 after he
was found incompetent to proceed in two criminal cases.1 His
symptoms, which he experienced intermittently for decades,
involved fluctuations between, on the one hand, depression, low
mood, and low energy, and on the other hand, mania with psychotic
symptoms, persecutory delusions, and aggressive behavior. He was
diagnosed with type I bipolar disorder. Due to his worsening manic
and psychotic symptoms and aggressive behavior, including an
1 Keene was initially admitted to the hospital to restore his
competency so he could stand trial in the criminal proceedings. A petition to administer involuntary medications to restore a defendant to competency is typically governed by Sell v. United States, 539 U.S. 166, 180-81 (2003). But Keene’s mental condition deteriorated while he was at the hospital. Thus, the petition’s stated purposes, and the district court’s bases for granting the petition, were (1) to prevent a significant and long-term deterioration in Keene’s mental condition and (2) to prevent the likelihood of him causing serious harm to himself or others. A petition to administer involuntary medication to a patient in these circumstances triggers the test set forth in People v. Medina, 705 P.2d 961, 973 (Colo. 1985). We therefore apply the Medina framework to the parties’ contentions.
1 incident in which he was verbally aggressive and physically
postured toward staff members, he was started on emergency
medications.
¶3 The People petitioned the district court for authorization to
involuntarily medicate Keene with the antipsychotic medication
olanzapine (Zyprexa) and the mood-stabilizing medication lithium
(jointly, the requested medications).
¶4 Keene and his psychiatrist, Dr. Zachary Wickline, both
testified at the hearing on the petition. Wickline described Keene’s
type I bipolar disorder as “severe” and a substantial disorder of the
cognitive, volitional, or emotion process that grossly impairs
judgment or capacity to recognize reality or to control behavior.”
Wickline proceeded to opine as follows:
• Keene has “little insight” into his mental illness because,
although he agrees that he has post-traumatic stress
disorder (PTSD), he does not believe he has bipolar
disorder.
• The requested medications are necessary to prevent both
a significant and likely long-term deterioration in his
2 bipolar disorder and the likelihood of him causing serious
harm to others in the hospital.
• There isn’t an alternative method of treating him that
would be both effective and less intrusive than the
requested medications because type I bipolar disorder
can only be effectively treated with medications.
• The failure to medicate Keene would be more harmful
than any risks posed by the requested medications.
¶5 Keene testified that he does not have a mental illness,
including bipolar disorder, but said that he does suffer from PTSD
and depression. He testified that he does not need any
antipsychotic or mood-stabilizing medications, but that Ativan (an
anti-anxiety medication) and melatonin (a sleep aid) have helped
him sleep. He also testified about the side effects he said he
experienced from the requested medications. He further clarified
that, although he doesn’t like psychiatry because “it doesn’t tend to
involve any kind of psychological therapy,” he is “very much in favor
of” psychological treatment, such as trauma-informed care and
dialectical behavior therapy.
3 ¶6 Following Keene’s testimony, the district court credited
Wickline’s testimony; examined each of the four elements of the test
from People v. Medina, 705 P.2d 961, 973 (Colo. 1985); concluded
that the People had met their burden of proving all four elements;
and granted the petition.
II. Applicable Law and Standard of Review
¶7 The parties agree that the Medina test applies. Under that
test, a district court may authorize the involuntary administration
of medication if the People demonstrate by clear and convincing
evidence that
(1) the patient is incompetent to effectively participate in the treatment decision;
(2) the treatment with medication is necessary to prevent a significant and likely long-term deterioration in the patient’s mental health condition or to prevent the likelihood of the patient causing serious harm to himself or others in the institution;
(3) a less intrusive treatment alternative is not available; and
(4) the patient’s need for treatment with medication is sufficiently compelling to override any bona fide and legitimate interest he has in refusing treatment.
Id.
4 ¶8 Application of the Medina test involves mixed questions of fact
and law. People v. Marquardt, 2016 CO 4, ¶ 8. We defer to the
district court’s factual findings if they have record support, while we
review the court’s legal conclusions de novo. Id. Resolving conflicts
in testimony and determining the credibility of the witnesses are
matters solely within the province of the district court. People in
Interest of Ramsey, 2023 COA 95, ¶ 23.
III. Analysis
¶9 Keene contends that the evidence was insufficient to establish
any of the four Medina elements by clear and convincing evidence.
We disagree.
¶ 10 On a sufficiency challenge, we must determine whether the
evidence, viewed as a whole and in the light most favorable to the
People, is sufficient to support the district court’s order. People in
Interest of R.K.L., 2016 COA 84, ¶ 13. The testimony of the
physician seeking to administer treatment may be sufficient,
without more, to satisfy the Medina test. Id. at ¶ 30.
A. The First Medina Element
¶ 11 To show that the patient is incompetent to effectively
participate in a treatment decision, the People must establish that
5 “the patient’s mental illness has so impaired his judgment as to
render him ‘incapable of participating in decisions affecting his
health.’” Medina, 705 P.2d at 973 (quoting Goedecke v. State, 603
P.2d 123, 125 (Colo. 1979)). But “[i]f the patient is competent to
participate in the treatment decision, then the patient’s refusal to
submit to the proposed treatment must be respected out of the
law’s regard for a person’s right to make decisions on matters
affecting his own bodily integrity.” Id.
¶ 12 In finding that Keene is incompetent to effectively participate
in the treatment decision, the district court credited Dr. Wickline’s
opinion that Keene has type I bipolar disorder, while emphasizing
that Keene does not believe he has a mental illness (other than
PTSD and depression). Based on that disagreement, the court
found that Keene has limited insight into his mental illness because
he does not understand “the significance of his diagnosis and the
need for medications.” Therefore, the court found, Keene “is
incapable of making informed treatment decisions.”
¶ 13 Those findings are supported by Dr. Wickline’s testimony that
Keene has “severe” type I bipolar disorder. Wickline opined that
Keene’s “lack of insight [into his mental illness] is the crucial piece”
6 supporting Wickline’s opinion that Keene is incompetent to
effectively participate in deciding whether psychiatric medications
are needed. As Wickline explained, Keene’s “detachment from
reality” makes him unable to understand his mental illness and his
need for the requested medications. (Id. at pp. 7-8) See R.K.L., ¶¶
6-7, 33 (affirming the finding that the patient was incompetent to
effectively participate in the treatment decision because the
psychiatrist testified that, while the patient had schizophrenia, the
patient did not think he had a mental illness); People in Interest of
Strodtman, 293 P.3d 123, 131-32 (Colo. App. 2011) (same).
¶ 14 Although Keene emphasizes that he has “a degree of insight”
into his mental illness because he recognizes that he has PTSD and
depression and is willing to take Ativan and melatonin, that ignores
the fact that he does not believe he has bipolar disorder, which is
the “severe” mental illness that requires treatment with the
requested medications. Keene also points out that he wants to get
psychological therapy without psychiatric medications. But, as
Wickline testified, “medication treatment would always be a part of
his treatment plan. Certainly therapies could help as well. But I
think he does require medications.”
7 ¶ 15 Given that the court credited Wickline’s testimony, the
evidence, viewed as a whole and in the light most favorable to the
People, is sufficient to support the district court’s finding on the
first Medina element. See Ramsey, ¶ 23; R.K.L., ¶¶ 13, 30.
B. The Second Medina Element
¶ 16 In Keene’s opening brief, he challenges the district court’s
finding that the second Medina element was met, but then, in his
reply brief, he states that he “does not challenge the [district
court’s] findings as to this element on appeal.” We resolve this
inconsistency by assuming that the statement in his reply brief was
an oversight, and that he does indeed seek review of all the
arguments raised in his opening brief. So, we turn to the district
court’s finding that the requested medications are necessary to
prevent a significant and likely long-term deterioration in Keene’s
mental condition.
¶ 17 Because we conclude that the evidence was sufficient on that
issue, we need not address whether the requested medications were
also necessary to prevent the likelihood of him causing serious
harm to himself or others in the hospital.
8 ¶ 18 In determining whether medication is necessary to prevent a
significant and likely long-term deterioration in a patient’s mental
condition, a court “should focus on the nature and gravity of the
patient’s illness, the extent to which the medication is essential to
effective treatment, the prognosis without the medication, and
whether the failure to medicate will be more harmful to the patient
than any risks posed by the medication.” Medina, 705 P.2d at 973.
¶ 19 The district court explicitly stated that it was relying on Dr.
Wickline’s testimony in finding that the requested medications are
necessary to prevent a significant and likely long-term deterioration
in Keene’s mental condition. Wickline explained his reasoning for
that opinion by addressing the considerations identified in Medina:
• He characterized Keene’s type I bipolar disorder as
“severe.”
• He testified that “when bipolar disorder has psychotic
features [as in Keene’s case], the medical consensus is
that you use . . . a mood stabilizer and an antipsychotic
together.” He further explained that (1) lithium “is the
gold standard mood stabilizer in people with bipolar
disorder” because it “can effectively reduce the symptoms
9 of mania and in doing so, hopefully reduce the symptoms
of psychosis,” and (2) olanzapine “more directly treats the
psychotic symptoms, so we would hope that the
symptoms of hearing voices[,] of disorganized speech and
thought[,] and delusional beliefs would be lessened.”
• He testified that, without the requested medications,
“there would be certainly the continuation of psychotic
symptoms” and “the longer and more persistent these
symptoms, . . . the more likely there is a long term
deterioration and worse[] long term outcomes.”
• He explained why the failure to medicate Keene would be
more harmful than any risks posed by the requested
medications.
¶ 20 In challenging the district court’s finding on this element,
Keene highlights Wickline’s testimony on cross-examination that
delusional beliefs are “often the most treatment resistant” and may
not fully resolve with pharmacological intervention, and that when
Keene has taken medication in the past, “[s]ome of [his] delusional
beliefs were maintained.” However, Wickline proceeded to testify
that “it is possible that his delusional beliefs could resolve,” but
10 given that he has experienced bipolar disorder for decades, “that
aspect of the illness” may not “fully resolve.” He also testified that,
even if Keene’s delusional beliefs do not fully resolve, Keene’s
“emotional reactions around those delusional beliefs can be
lessened” and “he will perhaps be less perseverative and fixated on
those beliefs.”
¶ 21 Regardless of whether Keene’s delusional beliefs could fully
resolve from treatment with the requested medications, the
important point is that Dr. Wickline’s testimony supported a
conclusion that the requested medications would help Keene
improve rather than deteriorate.
C. The Third Medina Element
¶ 22 Similar to his contention regarding the second Medina
element, Keene’s opening brief presents arguments challenging the
district court’s finding that the third Medina element was met, but
then in his reply brief, he states that he “does not challenge the
[district court’s] findings as to this element on appeal.” Here too,
we will assume that Keene seeks review of the arguments he raises
in his opening brief.
11 ¶ 23 For purposes of this Medina element, “a ‘less intrusive
alternative’ constitutes an available treatment that has less harmful
side effects and is at least as effective at alleviating a patient’s
condition as the proposed treatment.” Strodtman, 293 P.3d at 133
(quoting Medina, 705 P.2d at 974). In evaluating this element, “the
focus encompasses not only the gravity of any harmful effects from
the proposed treatment but also the existence, feasibility, and
efficacy of alternative methods of treating the patient’s condition.”
Medina, 705 P.2d at 974.
¶ 24 The district court found that there was no less intrusive
alternative to administration of the requested medications,
explaining how lithium and olanzapine work to treat type I bipolar
disorder. That finding is supported by Wickline’s testimony that (1)
“when bipolar disorder has psychotic features [as in Keene’s case],
the medical consensus is that you use . . . a mood stabilizer and an
antipsychotic together”; and (2) although “therapies could help as
well,” Keene “does require medications.”
¶ 25 Keene asserts that “Dr. Wickline testified that [l]ithium alone
could be sufficient to address [his] symptoms.” We are
unpersuaded because, although Wickline testified it was “possible”
12 that lithium alone could treat Keene’s symptoms, he continued by
testifying that, “given the degree of impairment owed to the
psychotic symptoms specifically, I do think that targeting them
directly with an antipsychotic is indicated.” And although Ativan
and melatonin helped Keene with insomnia, those medications are
not the antipsychotics or mood stabilizers needed to treat his
bipolar disorder. And regarding Keene’s desire to be treated with
psychological treatment, rather than with psychiatric medications,
Wickline conceded that “therapies could help as well.” But he did
not waver from his opinion that Keene “does require medications.”
D. The Fourth Medina Element
¶ 26 In analyzing the fourth Medina element, a court first
determines “whether the patient’s refusal [of treatment] is bona fide
and legitimate.” Medina, 705 P.2d at 974. If it is, the court then
determines “whether the prognosis without treatment is so
unfavorable that the patient’s personal preference must yield to the
legitimate interests of the state in preserving the life and health of
the patient placed in its charge and in protecting the safety of those
in the institution.” Id.
13 ¶ 27 The district court noted Keene’s testimony about the
numerous side effects he said he experienced from the requested
medications but then credited Wickline’s testimony that Keene
tolerated the requested medications well when he took them on an
emergency basis. So, the court found, Keene’s reported side effects
were “not necessarily” bona fide and legitimate. But the court also
found that, even if Keene’s complaints about side effects were bona
fide and legitimate, his prognosis if he did not take the requested
medications would be so unfavorable that his interests in avoiding
side effects must yield to the “legitimate interests of the state in
preserving the life and health of the patient who [was] placed in its
charge and protecting the safety of those in the institution.”
¶ 28 Before discussing the issue of side effects, we first note that
Keene identifies on appeal another interest in refusing the
requested medications, namely, that testing has revealed that he
has decreased blood counts, which could indicate a broad range of
serious underlying conditions. However, Keene did not testify on
this issue, and Wickline noted that (1) Keene refused to see a
hematologist regarding the low blood counts; (2) he hoped that
Keene would be more willing to see a hematologist as his psychotic
14 symptoms and mood improve on the requested medications; and
(3) “a wide range of things” could cause the low blood counts. So,
there is little to no reason to think that the requested medications
played any role in Keene’s low blood counts, particularly given that
he had low blood counts when he was admitted to the hospital.
¶ 29 In addition, Keene asserts that he experienced “debilitating”
side effects from the requested medications, including cognitive
decline, physical pain, physical impairment, dry mouth, tremors,
dizziness, restlessness, sedation, and depression. He also testified
that he experienced negative reactions to similar medications in the
past. Finally, he emphasizes the potential side effects of the
requested medications, as Wickline testified.
¶ 30 In light of Wickline’s testimony that he observed only that
Keene was “a little bit slower,” was “a little bit more tired,” and had
“a little bit depressed mood stage” when he took the requested
medications on an emergency basis, we acknowledge the district
court’s skepticism as to whether Keene’s list of endorsed side effects
was bona fide and legitimate. However, like the district court, we
will assume, without deciding, that his interest in avoiding side
effects is bona fide and legitimate.
15 ¶ 31 The question then turns to whether Keene’s need for treatment
with the requested medications is sufficiently compelling to override
his interest in avoiding their side effects. On appeal, Keene does
not specifically address this issue but, having challenged the
second Medina element regarding whether the requested
medications are necessary to prevent a significant and likely
long-term deterioration in his condition, he implicitly did.
¶ 32 Given our analysis of the second Medina element in Part III.B
above, we discern no error in the district court’s assessment of the
fourth Medina element. When viewed as a whole and in the light
most favorable to the People, Wickline’s unequivocal testimony
regarding the reasons why the court should order the involuntary
administration of the requested medications establishes that
Keene’s compelling need for treatment outweighs his interest in
avoiding side effects. Ramsey, ¶ 23; R.K.L., ¶¶ 13, 30. Recall that
Wickline testified that Keene’s type I bipolar disorder, which he has
had for decades, is severe; an antipsychotic medication and a
mood-stabilizing medication are necessary to effectively treat the
condition; and without the requested medications, he would
experience a significant and likely long-term deterioration in the
16 condition. Further, Wickline specifically opined that not treating
Keene with the requested medications would be more harmful than
their risks.
IV. Disposition
¶ 33 The order is affirmed.
JUDGE LIPINSKY and JUDGE YUN concur.